Gönül DİNÇ HORASAN, Sema BİLGE, Fatma TANELİ, Koray ERBÜYÜN, Gülay OK, Demet AYDIN, Canan GÜRSOY

Neurological outcome after cardiac arrest: a prospective study of the predictive ability of prognostic biomarkers neuron-specific enolase, glial fibrillary acidic protein, S-100B, and procalcitonin

Background/aim: Factors affecting neurological outcome and the usefulness of neuron-specific enolase (NSE), S-100B, glial fibrillary acidic protein (GFAP), and procalcitonin (PCT) in predicting neurological outcomes were assessed in patients who survived at least 24 h after cardiopulmonary resuscitation (CPR). Materials and methods: Thirty successfully resuscitated cardiac arrest patients were included in this prospective clinical study. The initial cardiac arrest rhythm, duration of CPR, return of spontaneous circulation time, administered doses of adrenaline, base excess, blood sugar, and hemodynamic parameters were recorded. Patients with Glasgow Outcome Scale (GOS) scores of 1 3 were defined as Group I and patients with GOS scores of 4 5 were defined as Group II. Serum NSE, GFAP, S-100B, and PCT levels were compared between the two groups shortly after CPR (hour 0) and at hours 12 and 24 of the postresuscitation period. Results: Serum S-100B was significantly higher (P = 0.009) in Group II immediately after CPR. Serum S-100B and NSE after CPR at hours 0, 12, and 24 were significantly lower in patients who survived to hospital discharge. Serum PCT at hours 12 and 24 and serum S-100B after CPR at 0, 12, and 24h reached 94.7% sensitivity. Serum NSE, GFAP, S-100B, and PCT specificities were lower than 50%. Conclusion: In predicting neurological outcomes, serum S-100B has high sensitivity and low specificity immediately after CPR.

PDF

___

1. Eisenberg M. Resuscitate! How Your Community Can Improve Survival from Sudden Cardiac Arrest. Seattle, WA, USA: University of Washington Press; 2009.
2. Krause GS, Kumar K, White BC, Aust SD, Wiegenstein JG. Ischemia, resuscitation, and reperfusion: mechanisms of tissue injury and prospects for protection. Am Heart J 1986; 111: 768-780.
3. Nolan JP, Neumar RW, Adrie C, Aibiki M, Berg RA, Böttiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC et al. Postcardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation 2008; 79: 350-379.
4. Albaeni A, Eid SM, Vaidya D, Chandra-Strobos N. Predicting survival with good neurological outcome within 24 hours following out of hospital cardiac arrest: the application and validation of a novel clinical score. J Neurol Transl Neurosci 2014; 2: 1041.
5. Malhotra S, Dhama SS, Kumar M, Jain G. Improving neurological outcome after cardiac arrest: therapeutic hypothermia the best treatment. Anesth Essays Res 2013; 7: 18-24.
6. Shinozaki K, Oda S, Sadahiro T, Nakamura M, Abe R, Nakada T, Nomura F, Nakanishi K, Kitamura N, Hirasawa H. Serum S 100B is superior to neuron specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation. Resuscitation 2009; 80: 870- 875.
7. Pfeifer R, Borner A, Figulla H. Outcome after cardiac arrestpredictive values and limitations of the neuroproteins neuronspecific enolase and protein S100 and the Glasgow Coma Scale. Resuscitation 2005; 65: 49-55.
8. Böttiger BW, Möbes S, Glätzer R, Bauer H, Gries A, Bärtsch P, Motsch J, Martin E. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001; 103: 2694-2698.
9. Zandbergen EG, Hijdra A, Koelman JH, Hart AA, Vos PE, Verbeek MM, de Haan RJ; PROPAC Study Group. Prediction of poor outcome within the first three days of postanoxic coma. Neurology 2006; 66: 62-68.
10. Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M, Gabrielli A, Silvers SM, Zaritsky AL, Merchant R et al. 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010; 122: 768-786.
11. Reisinger J, Höllinger K, Lang W, Steiner C, Winter T, Zeindlhofer E, Mori M, Schiller A, Lindorfer A, Wiesinger K et al. Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron specific enolase. Eur Heart J 2007; 28: 52-58.
12. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S100B and glial fibrillary acidic protein. Stroke 2000; 31: 2670- 2677.
13. Nylén K, Csajbok LZ, Ost M, Rashid A, Blennow K, Nellgard B. Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38: 1489-1494.
14. Hayashida H, Kaneko T, Kasaoka S, Oshima C, Miyauchi T, Fujita M, Oda Y, Tsuruta R, Maekawa T. Comparison of the predictability of neurological outcome by serum procalcitonin and glial fibrillary acidic protein in postcardiac-arrest patients. Neurocrit Care 2010; 12: 252-257.
15. Bakar B, Sumer MM, Tekkok IH. Decompressive craniectomy for intractable intracranial hypertension. Journal of Clinical and Analytical Medicine 2012; 3: 383-387.
16. Serrador JM, Milberg WP, Lipsitz LA. Cerebral hemodynamics in the elderly. In: Paul RH, Cohen R, Ott BR, Salloway S, editors. Vascular Dementia. Berlin, Germany: Springer; 2005. pp. 75-78.
17. Ginsberg MD, Welsh FA, Budd WW. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat. I. Local cerebral blood flow and glucose utilization. Stroke 1980; 11: 347-354.
18. Longstreth WT Jr, Diehr P, Cobb LA, Hanson RW, Blair AD. Neurologic outcome and blood glucose levels during out-ofhospital cardiopulmonary resuscitation. Neurology 1986; 36: 1186-1191.
19. Müllner M, Sterz F, Binder M, Schreiber W, Deimel A, Laggner AN. Blood glucose concentration after cardiopulmonary resuscitation influences functional neurological recovery in human cardiac arrest survivors. J Cerebr Blood F Met 1997; 17: 430-436.
20. Sandroni C, Nolan J, Cavallaro F, Antonelli M. In-hospital cardiac arrest: incidence, prognosis and possible measures to improve survival. Intensive Care Med 2007; 33: 237-245.
21. Holmberg M, Holmberg S, Herlitz J; Swedish Cardiac Arrest Registry. Factors modifying the effect of bystander cardiopulmonary resuscitation on survival in out-of-hospital cardiac arrest patients in Sweden. Eur Heart J 2001; 22: 511- 519.
22. Grubb NR, Simpson C, Sherwood RA, Abraha HD, Cobbe SM, OCarroll RE, Deary I, Fox KA. Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100. Heart 2007; 93: 1268-1273.
23. Auer J, Berent R, Weber T, Porodko M, Lamm G, Lassnig E, Maurer E, Mayr H, Punzengruber C, Eber B. Ability of neuronspecific enolase to predict survival to hospital discharge after successful cardiopulmonary resuscitation. Can J Emerg Med Care 2006; 8: 13-18.
24. Dash PK, Zhao J, Hergenroeder G, Moore AN. Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics 2010; 7: 100-114.
25. Calderon LM, Guyette FX, Doshi AA, Callaway CW, Rittenberger JC. Post cardiac arrest service. Combining NSE and S100B with clinical examination findings to predict survival after resuscitation from cardiac arrest. Resuscitation 2014; 85: 1025-1029.
26. Tiainen M, Roine RO, Pettilä V, Takkunen O. Serum neuronspecific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke 2003; 34: 2881-2886.
27. Zorzia A, Gasparetto N, Stella F, Bortoluzzi A, Cacciavillani L, Basso C. Surviving out of hospital cardiac arrest: just a matter of defibrillators? J Cardiovasc Med 2014; 15: 616-623.
28. Zingler VC, Krumm B, Bertsch T, Fassbender K, PohlmannEden B. Early prediction of neurological outcome after cardiopulmonary resuscitation: a multimodal approach combining neurobiochemical and electrophysiological investigation smay provide high prognostic certainty in patients after cardiac arrest. Eur Neurol 2003; 49: 79-84.
29. Prohl J, Röther J, Kluge S, de Heer G, Liepert J, Bodenburg S, Pawlik K, Kreymann G. Prediction of short-term and long-term outcomes after cardiac arrest: a prospective multivariate approach combining biochemical, clinical, electrophysiological, and neuropsychological investigations. Crit Care Med 2007; 35: 1230-1237.
30. Rech TH, Vieira SR, Nagel F, Brauner JS, Scalco R. Serum neuron-specific enolase as early. Crit Care 2006; 10: 133.
31. Hachimi-Idrissi S, Van der Auwera M, Schiettecatte J, Ebinger G, Michotte Y, Huyghens L. S-100 protein as early predictor of regaining consciousness after out of hospital cardiac arrest. Resuscitation 2002; 53: 251-257.
32. Larsson IM, Wallin E, Kristofferzon ML, Niessner M, Zetterberg H, Rubertsson S. Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome. Resuscitation. 2014; 85: 1654-1661.